| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/03/2011 | EP2349342A1 Modified blood factors comprising a low degree of water soluble polymer |
| 08/03/2011 | EP2349332A2 Methods and compositions for regulating iron homeostasis by modulation bmp-6 |
| 08/03/2011 | EP2349256A1 Heterocyclic benzimidazoles as trpm8 modulators |
| 08/03/2011 | EP2349228A1 Iron source product in the form of capsules and process for their preparation |
| 08/03/2011 | EP1809268B1 Alpha-humulene for use in the prophylaxis or treatment of inflammatory pain or oedema |
| 08/03/2011 | EP1688488B1 Bispecific antibody substituting for factor viii |
| 08/03/2011 | CN1891687B Inflammatory factor receptor antagonistic active compound from microbe and its use |
| 08/03/2011 | CN1700934B Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 08/03/2011 | CN102143761A Agent for treating myelofibrosis |
| 08/03/2011 | CN102143754A Composition comprising crystallisation inhibitory substances |
| 08/03/2011 | CN102140064A Compounds for the treatment of metabolic disorders |
| 08/03/2011 | CN102139114A Polymer factor VIII moiety conjugates |
| 08/03/2011 | CN102139092A Leech freeze-dried powder injection solution for injection and preparation method thereof |
| 08/03/2011 | CN102139065A Capsule prepared from Chinese herbal medicines for treating cardiovascular and cerebrovascular diseases |
| 08/03/2011 | CN102139013A Health care tonic wine for strengthening yang |
| 08/03/2011 | CN102139010A Traditional Chinese medicine for treating postabortal colporrhagia |
| 08/03/2011 | CN102138981A Preparation method of plantago seed polysaccharide extractive and applications thereof |
| 08/03/2011 | CN102138976A Preparation method of mulberry particles |
| 08/03/2011 | CN102138971A Quality detection method for RuanGanXiaoShui cataplasma |
| 08/03/2011 | CN102138967A Application of dracocephalum moldavica L. general flavone in preparing medicament for preventing and treating cerebrovascular disease |
| 08/03/2011 | CN102138960A Novel extraction process of dalbergiae oil through super (sub) critical carbon dioxide |
| 08/03/2011 | CN102138953A Application of chorispora bungeana or extract thereof in preparation of medicaments for preventing and treating cardiovascular and cerebrovascular diseases |
| 08/03/2011 | CN102138951A Preparation method of gynura japonica alkaloid |
| 08/03/2011 | CN102138945A Method of extracting active substances with high content of flavones from ginkgo leaves |
| 08/03/2011 | CN102138943A Chinese medicinal preparation for treating anemia |
| 08/03/2011 | CN102138935A Melanterite-containing medicinal composition and preparation method thereof |
| 08/03/2011 | CN102138933A Production process of ferrous sulfate sustained-release tablet |
| 08/03/2011 | CN102138932A Buffered compositions for dialysis |
| 08/03/2011 | CN102138929A Surgical hemostat for pets and preparation method thereof |
| 08/03/2011 | CN102138919A New application of sodium ferrous chlorophyll to promotion of erythropoiesis |
| 08/03/2011 | CN101804159B Traditional Chinese medicine preparation for treating aplastic anemia |
| 08/03/2011 | CN101427722B Blood nourishing and calcium replenishing crunchy candy of donkey-hide gelatin |
| 08/03/2011 | CN101275126B Purified high-specific-activity recombinant batroxobin |
| 08/02/2011 | US7989490 Injectable formulations of taxanes for cad treatment |
| 08/02/2011 | US7989424 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 08/02/2011 | CA2470956C 1-alkyl-1-azoniabicyclo[2.2.2]octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 08/02/2011 | CA2447632C Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor |
| 08/02/2011 | CA2323207C Food products having enhanced cocoa polyphenol content and processes for producing same |
| 07/28/2011 | WO2011091164A1 Oral dosage forms having a high loading of a tranexamic acid prodrug |
| 07/28/2011 | WO2011091122A1 Methods for internally controlling or treating equine bot larvae |
| 07/28/2011 | WO2011090306A2 Liquid formulations for long-acting erythropoietin conjugate |
| 07/28/2011 | WO2011090062A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | WO2011088751A1 A human factor ix slow release dosage form |
| 07/28/2011 | US20110184220 Methods for the treatment of radiation or chemotherapy-induced tissue damage |
| 07/28/2011 | US20110184060 Oral dosage forms having a high loading of a tranexamic acid prodrug |
| 07/28/2011 | US20110184049 Liver-specific nucleic acid regulatory elements and methods and use thereof |
| 07/28/2011 | US20110184046 Compositions And Methods For Inhibiting Expression Of GSK-3 Genes |
| 07/28/2011 | US20110184034 Severe sepsis preventive therapeutic agent |
| 07/28/2011 | US20110184001 Inhibitors of bruton's tyrosine kinase |
| 07/28/2011 | US20110183984 Small molecule inhibitors of lck sh2 domain binding |
| 07/28/2011 | US20110183979 Nitrogen-containing heteroaryl derivatives |
| 07/28/2011 | US20110183973 Novel Compounds |
| 07/28/2011 | US20110183948 Treatment of fibrotic conditions using hedgehog inhibitors |
| 07/28/2011 | US20110183907 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
| 07/28/2011 | US20110183906 Factor ix conjugates with extended half-lives |
| 07/28/2011 | US20110183890 Methods for modulating angiogenesis via dystrophin dp71 |
| 07/28/2011 | US20110182989 Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites |
| 07/28/2011 | US20110182985 Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof |
| 07/28/2011 | US20110182943 Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments |
| 07/28/2011 | US20110182919 Immunoglobulin Chimeric Monomer-Dimer Hybrids |
| 07/28/2011 | US20110182899 Anti-glycoptrotein vi scfv fragment for treatment of thrombosis |
| 07/28/2011 | US20110182896 CLOTTING FACTOR-Fc CHIMERIC PROTEINS TO TREAT HEMOPHILIA |
| 07/28/2011 | US20110182876 Methods of Treatment with Elastase |
| 07/28/2011 | US20110182867 Modulation of bcl11a for treatment of hemoglobinopathies |
| 07/28/2011 | CA2787652A1 Liquid formulations for long-acting erythropoietin conjugate |
| 07/28/2011 | CA2787248A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | CA2787078A1 Methods for internally controlling or treating equine bot larvae |
| 07/28/2011 | CA2786776A1 Drug-eluting insertable medical device for treating acute myocardial infarction, thrombus containing lesions and saphenous-vein graft lesions |
| 07/27/2011 | EP2348018A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient |
| 07/27/2011 | EP2346527A1 Medicinal products for the treatment of blood coagulation disorders containing thrombin-free factor xia concentrate |
| 07/27/2011 | EP1436387B1 Enzymatic conversion of blood group b, and ab red blood cells using an alpha-galactosidase with unique substrate specificities and kinetic properties |
| 07/27/2011 | EP1011743B1 Loading and release of water-insoluble drugs |
| 07/27/2011 | CN1814196B Chinese medicine composition for treating functional metrorrhagia and preparation method thereof |
| 07/27/2011 | CN1393222B Use of composition of sterol compounds dissolved in oil |
| 07/27/2011 | CN1309666B Polymer composition of glucuronic acid glucosan |
| 07/27/2011 | CN102134316A Polyasparagine-L-arginine and preparation method and medical application thereof |
| 07/27/2011 | CN102134315A Polyasparaginyl-L-alanine, preparation method and medical use thereof |
| 07/27/2011 | CN102134230A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102133350A Traditional Chinese medicine preparation for treating epistaxis and preparation method thereof |
| 07/27/2011 | CN102133308A Capsule for removing toxin and eliminating fat |
| 07/27/2011 | CN102133298A Two-aqueous-phase method for extracting total saponin from bittersweet herb |
| 07/27/2011 | CN102133291A Traditional Chinese medicine preparation for treating anemia caused by infant spleen deficiency and preparation method thereof |
| 07/27/2011 | CN102133278A Preparation method of 98% of paeoniflorin radix in radix paeoniae alba extract |
| 07/27/2011 | CN102133194A Preparation method and application of tanshinone II A solid dispersion pellets |
| 07/27/2011 | CN102133188A Cilostazol liposome solid preparation |
| 07/27/2011 | CN102133182A Epoprostenol liposome and preparation method thereof |
| 07/27/2011 | CN102132873A Medicine or health-care food for supplementing blood and regulating immunity |
| 07/27/2011 | CN101940595B Calf spleen extract for treating tumors |
| 07/27/2011 | CN101791362B Traditional Chinese medicine preparation for treatment of apoplexy |
| 07/27/2011 | CN101637464B Drug composite containing calcium 2,5-dihydroxysulfonate and ADP receptor antagonist |
| 07/27/2011 | CN101602765B 6-alkyl amino-2-alkylthio-9-ester-containing alkylpurine derivatives and method for synthesizing same |
| 07/27/2011 | CN101401819B Donkey-hide gelatin effervescent particle and preparation method thereof |
| 07/27/2011 | CN101279052B Haemostatic and uses thereof and preparation |
| 07/27/2011 | CN101249176B Chinese medicine prescription for steaming and soaking foots |
| 07/27/2011 | CN101094835B Novel dicarboxamide derivatives |
| 07/26/2011 | US7985887 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2011 | US7985846 Hemostatically active vWF-containing preparation and process for the preparation thereof |
| 07/26/2011 | US7985563 HIFαprolyl hydroxylation assay |
| 07/26/2011 | CA2484981C 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 07/26/2011 | CA2445344C Heterocyclic compound derivatives and medicines |